Objective: To investigate the electrophysiological and morphological changes of retinae after intravitreal injection of cyclosporin A (CsA) in experimental diabetic rats.
Methods: Experimental study. SD diabetic mellitus (DM) rat models were induced with intraperitoneal injection of streptozotocin. The rats were divided into four groups, with 9 rats in each group:the normal control (group CON), the diabetic rats with or without CsA intravitreal injection respectively (group DM + CsA and group DM), and the diabetic rats with dimethyl sulfoxide (DMSO) intravitreal injection (group DM + DMSO). The intravitreal injection of CsA or contrast solution was performed 4 weeks after the modeling. The retinal function of rats was examined by electroretinogram (ERG) 48 hours after the intravitreal injection. All rats were sacrificed and the structural changes of retina were observed by optical and transmission electron microscope. The datas of ERG including amplitudes and latencies of a-wave and b-wave were analyzed by One-way ANOVA and Bonferroni post hoc test.
Results: There was difference in ERG b-wave among the 4 groups under different stimuli light intensity (F = 14.760 - 28.890, all P value < 0.01). And there was difference in ERG a-wave among the 4 groups when the stimuli light intensity ≥ -0.35 log cd×s×m(-2) (F = 12.510, 15.500, both P value < 0.01). Comparing to the group CON (ERG a-wave: 82.43 ± 26.68, ERG b-wave: 208.40 ± 51.20), the ERG a-wave and b-wave amplitudes of group DM (ERG a-wave: 39.71 ± 7.61, ERG b-wave: 92.20 ± 24.42) and group DM + DMSO (ERG a-wave: 37.63 ± 17.25, ERG b-wave: 93.11 ± 22.50)(t = 5.448 - 7.872, all P value < 0.05), and the ERG b-wave of group DM + CsA (160.10 ± 43.39) (t = 3.299, P < 0.05) were declined in dark adaptation, while the ERG a-wave (63.91 ± 20.32) of group DM ± CsA had no difference (P > 0.05). The a-wave and b-wave amplitudes of group DM + CsA were significantly increased compared to the other two groups in dark adaptation (t = 3.203 - 4.759, both P < 0.05). Under optical microscope, group DM, DM + DMSO and DM + CsA had outer nuclear layer (ONL) disorder. Under transmission electron microscope, there were ultrastructure changes of the three groups. Furthermore, the ONL disorder and ultrastructure changes of group DM + CsA were less severe than the other two groups.
Conclusions: Functional and morphological changes are evident in the early stages in DM rats. Intravitreal injection with CsA shows protective effects on the nerve function in DM retina.
Download full-text PDF |
Source |
---|
JAMA Ophthalmol
January 2025
Truhlsen Eye Center, Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha.
Importance: Randomized clinical trials have shown the safety and efficacy of faricimab as a novel vascular endothelial growth factor and angiopoietin-2 inhibitor in the treatment of neovascular age-related macular degeneration (nAMD) and macular edema of various etiologies. However, more rare adverse events may not be considered in clinical trials.
Objective: To describe 3 eyes that developed irreversible vision loss following initial mild intraocular inflammation (IOI) to faricimab.
Amyloid β (Aβ) has emerged as a pathophysiological driver in age-related macular degeneration (AMD), emphasizing its significance in the aetiology of this prevalent sight-threatening condition. The multifaceted nature of AMD pathophysiology, presumably involving diverse retinal cascades, corresponds with the complexity of Aβ-induced retinopathy. Therefore, targeting a broad array of pathogenic processes holds promise for therapeutic intervention in AMD-associated retinal pathology.
View Article and Find Full Text PDFBMJ Case Rep
January 2025
ABRI, LV Prasad Eye Institute, GMRV Campus, Visakhapatnam, Andhra Pradesh, India
Bleb-like retinal detachment (BLRD) in posterior zone 1 retinopathy of prematurity (ROP) presents a significant therapeutic challenge and is associated with a guarded visual prognosis. We present a case of a female infant born preterm with a birth weight of 1100 g. Examination revealed bilateral stage 4 aggressive ROP in posterior zone 1 with BLRD.
View Article and Find Full Text PDFOphthalmol Retina
January 2025
Singapore Eye Research Institute, Singapore; Singapore National Eye Centre, Singapore; Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore. Electronic address:
Topic: To evaluate the prognosis of retinal fluid resolution in neovascular age-related macular degeneration (nAMD) after initiating treatment in terms of the prevalence of eyes with retinal fluid, the proportion of eyes which never achieve a fluid-free retina throughout the course of treatment, and the relationship between retinal fluid and visual acuity outcome.
Clinical Relevance: Retinal fluid often persists or recurs after initiating treatment for nAMD. It is unclear what proportion never achieve fluid resolution throughout their treatment course.
J Ocul Pharmacol Ther
January 2025
Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India.
Posterior segment ocular diseases, such as diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion, are leading causes of vision impairment and blindness worldwide. Effective management of these conditions remains a formidable challenge due to the unique anatomical and physiological barriers of the eye, including the blood-retinal barrier and rapid drug clearance mechanisms. To address these hurdles, nanostructured drug delivery systems are proposed to overcome ocular barriers, target the retina, and enhance permeation while ensuring controlled release.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!